In both the Easyhaler DPI and Evohaler pMDI cohorts, 98.3% of patients with asthma recovered FEV1 to at least -10% of baseline after their last treatment post MC test. Investigators sought to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback